194 related articles for article (PubMed ID: 24710624)
1. NRAGE promotes cell proliferation by stabilizing PCNA in a ubiquitin-proteasome pathway in esophageal carcinomas.
Yang Q; Ou C; Liu M; Xiao W; Wen C; Sun F
Carcinogenesis; 2014 Jul; 35(7):1643-51. PubMed ID: 24710624
[TBL] [Abstract][Full Text] [Related]
2. NRAGE is involved in homologous recombination repair to resist the DNA-damaging chemotherapy and composes a ternary complex with RNF8-BARD1 to promote cell survival in squamous esophageal tumorigenesis.
Yang Q; Pan Q; Li C; Xu Y; Wen C; Sun F
Cell Death Differ; 2016 Aug; 23(8):1406-16. PubMed ID: 27035619
[TBL] [Abstract][Full Text] [Related]
3. The F-box protein FBXO7 positively regulates bone morphogenetic protein-mediated signaling through Lys-63-specific ubiquitination of neurotrophin receptor-interacting MAGE (NRAGE).
Kang J; Chung KC
Cell Mol Life Sci; 2015 Jan; 72(1):181-95. PubMed ID: 24947323
[TBL] [Abstract][Full Text] [Related]
4. Knockdown of
Liu L; Cui Z; Zhang J; Wang J; Gu S; Ma J; Chen H; Hang L; Yang J; Shi Y
Cancer Biother Radiopharm; 2020 Feb; 35(1):41-49. PubMed ID: 31916845
[No Abstract] [Full Text] [Related]
5. EpCAM, a potential therapeutic target for esophageal squamous cell carcinoma.
Matsuda T; Takeuchi H; Matsuda S; Hiraiwa K; Miyasho T; Okamoto M; Kawasako K; Nakamura R; Takahashi T; Wada N; Kawakubo H; Saikawa Y; Omori T; Kitagawa Y
Ann Surg Oncol; 2014 Jun; 21 Suppl 3():S356-64. PubMed ID: 24566863
[TBL] [Abstract][Full Text] [Related]
6. miR-214 inhibits invasion and migration via downregulating GALNT7 in esophageal squamous cell cancer.
Lu Q; Xu L; Li C; Yuan Y; Huang S; Chen H
Tumour Biol; 2016 Nov; 37(11):14605-14614. PubMed ID: 27619677
[TBL] [Abstract][Full Text] [Related]
7. Characterization of a candidate tumor suppressor gene uroplakin 1A in esophageal squamous cell carcinoma.
Kong KL; Kwong DL; Fu L; Chan TH; Chen L; Liu H; Li Y; Zhu YH; Bi J; Qin YR; Law SY; Guan XY
Cancer Res; 2010 Nov; 70(21):8832-41. PubMed ID: 20978196
[TBL] [Abstract][Full Text] [Related]
8. CD10 expression is enhanced by Twist1 and associated with poor prognosis in esophageal squamous cell carcinoma with facilitating tumorigenicity in vitro and in vivo.
Lee KW; Sung CO; Kim JH; Kang M; Yoo HY; Kim HH; Um SH; Kim SH
Int J Cancer; 2015 Jan; 136(2):310-21. PubMed ID: 24895167
[TBL] [Abstract][Full Text] [Related]
9. Identification of novel NRAGE involved in the radioresistance of esophageal cancer cells.
Zhou H; Zhang G; Xue X; Yang Y; Yang Y; Chang X; Ge X; Xiao Z; Guo H; Wang Y
Tumour Biol; 2016 Jul; 37(7):8741-52. PubMed ID: 26738870
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of sex-determining region Y-box 9 (SOX9) promotes cell proliferation and tumorigenicity in esophageal squamous cell carcinoma.
Hong Y; Chen W; Du X; Ning H; Chen H; Shi R; Lin S; Xu R; Zhu J; Wu S; Zhou H
Oncotarget; 2015 Oct; 6(31):31241-54. PubMed ID: 26384302
[TBL] [Abstract][Full Text] [Related]
11. Knockdown of neurotrophin receptor-interacting melanoma-associated antigen homolog inhibits acute myeloid leukemia cell growth via the ERK pathway.
Zhang H; Wu G; Chen B
Chin J Physiol; 2023; 66(4):276-283. PubMed ID: 37635487
[TBL] [Abstract][Full Text] [Related]
12. miR-942 promotes cancer stem cell-like traits in esophageal squamous cell carcinoma through activation of Wnt/β-catenin signalling pathway.
Ge C; Wu S; Wang W; Liu Z; Zhang J; Wang Z; Li R; Zhang Z; Li Z; Dong S; Wang Y; Xue Y; Yang J; Tan Q; Wang Z; Song X
Oncotarget; 2015 May; 6(13):10964-77. PubMed ID: 25844602
[TBL] [Abstract][Full Text] [Related]
13. PKC iota promotes cellular proliferation by accelerated G1/S transition via interaction with CDK7 in esophageal squamous cell carcinoma.
Ni S; Chen L; Li M; Zhao W; Shan X; Wu M; Cheng J; Liang L; Wang Y; Jiang W; Zhang J; Ni R
Tumour Biol; 2016 Oct; 37(10):13799-13809. PubMed ID: 27481515
[TBL] [Abstract][Full Text] [Related]
14. TGFBI Expression in Cancer Stromal Cells is Associated with Poor Prognosis and Hematogenous Recurrence in Esophageal Squamous Cell Carcinoma.
Ozawa D; Yokobori T; Sohda M; Sakai M; Hara K; Honjo H; Kato H; Miyazaki T; Kuwano H
Ann Surg Oncol; 2016 Jan; 23(1):282-9. PubMed ID: 25448803
[TBL] [Abstract][Full Text] [Related]
15. MDM2 is overexpressed and regulated by the eukaryotic translation initiation factor 4E (eIF4E) in human squamous cell carcinoma of esophagus.
Hsu HS; Chen HW; Kao CL; Wu ML; Li AF; Cheng TH
Ann Surg Oncol; 2011 May; 18(5):1469-77. PubMed ID: 21080085
[TBL] [Abstract][Full Text] [Related]
16. Insulin-like growth factor-1 receptor as a novel prognostic marker and its implication as a cotarget in the treatment of human adenocarcinoma of the esophagus.
Kalinina T; Bockhorn M; Kaifi JT; Thieltges S; Güngör C; Effenberger KE; Strelow A; Reichelt U; Sauter G; Pantel K; Izbicki JR; Yekebas EF
Int J Cancer; 2010 Oct; 127(8):1931-40. PubMed ID: 20104520
[TBL] [Abstract][Full Text] [Related]
17. STC2: a predictive marker for lymph node metastasis in esophageal squamous-cell carcinoma.
Kita Y; Mimori K; Iwatsuki M; Yokobori T; Ieta K; Tanaka F; Ishii H; Okumura H; Natsugoe S; Mori M
Ann Surg Oncol; 2011 Jan; 18(1):261-72. PubMed ID: 20734150
[TBL] [Abstract][Full Text] [Related]
18. BRCA1-Associated Protein Increases Invasiveness of Esophageal Squamous Cell Carcinoma.
Zhao Y; Wei L; Shao M; Huang X; Chang J; Zheng J; Chu J; Cui Q; Peng L; Luo Y; Tan W; Tan W; Lin D; Wu C
Gastroenterology; 2017 Nov; 153(5):1304-1319.e5. PubMed ID: 28780075
[TBL] [Abstract][Full Text] [Related]
19. WNT10A promotes an invasive and self-renewing phenotype in esophageal squamous cell carcinoma.
Long A; Giroux V; Whelan KA; Hamilton KE; Tétreault MP; Tanaka K; Lee JS; Klein-Szanto AJ; Nakagawa H; Rustgi AK
Carcinogenesis; 2015 May; 36(5):598-606. PubMed ID: 25795715
[TBL] [Abstract][Full Text] [Related]
20. Integrin alpha 6: a novel therapeutic target in esophageal squamous cell carcinoma.
Kwon J; Lee TS; Lee HW; Kang MC; Yoon HJ; Kim JH; Park JH
Int J Oncol; 2013 Nov; 43(5):1523-30. PubMed ID: 24042193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
